Colgate-Palmolive’s second quarter results were met with a cautious market response, as the company’s revenue matched Wall ...

Colgate-Palmolive (CL) fell in early trading on Friday after its second-quarter earnings report. Revenue was up 4.9% to ...

Colgate-Palmolive: Hold rating as valuation looks rich amid weak North America and slow organic growth. Click for more on CL ...

A 15% year-to-date loss at a time when broader benchmarks are flirting with all-time highs may be enough to cause some investors to write off Colgate-Palmolive, but there are some sparks that could ...

Consumer goods manufacturer Colgate-Palmolive (NYSE:CL) reported mixed fourth-quarter and full-year 2024 earnings on Friday, Jan. 31. Adjusted earnings per share (EPS) for Q4 rose to $0.91, surpassing ...

Colgate-Palmolive stock has delivered a 30.8% return over the past five years, yet there is a split in what the valuation ...

Colgate-Palmolive Company Q2 results: stable revenue, solid margins, and regional growth trends. Click for this CL earnings review and see if it is right for you.

Colgate-Palmolive India reports Q1 profit up 7% to ₹343.08 crore, driven by premium toothpaste demand and 12% sales growth.

Colgate-Palmolive India Ltd on Thursday reported 7 per cent rise in net profit at Rs 343.08 crore for June quarter FY27 ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

With consumer staples stocks out of favor, Colgate-Palmolive's share price slumped in 2025. The company has accelerated its product development pace. Colgate-Palmolive has met or exceeded its organic ...